beta

PDLI

PDL Biopharma Inc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Market Cap: 296 Million

Primary Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET)

Website: http://pdl.com/

Shares Outstanding: 114 Million

Float: 0

Dividend: 0.07096252269049486 (0.03%)

Beta: 0.7382132027243871

Sector: Manufacturing

Industry: Biological Product (except Diagnostic) Manufacturing

Ethical Flags

Longest drawdown: 1682 trading days

From: 2014-09-02 To: 2020-11-27

Lowest Point:

Evofem Biosciences Closes $80 Million Financing Transaction with PDL BioPharma and Other Long-time Investors

via: PR Newswire at 2019-06-10 12:01:00:000

SAN DIEGO and INCLINE VILLAGE, Nev. , June 10, 2019 /PRNewswire/ --Evofem Biosciences, Inc. (NASDAQ: EVFM) (Evofem), a clinical-stage biopharmaceutical company, and PDL BioPharma, Inc. (Nasdaq: PDLI) (PDL) today announced the closing of the second tranche for $50 million of an a… read more...

Evofem Biosciences Closes $80 Million Financing Transaction with PDL BioPharma and Other Long-time Investors

via: PR Newswire at 2019-06-10 12:01:00:000

SAN DIEGO and INCLINE VILLAGE, Nev. , June 10, 2019 /PRNewswire/ --Evofem Biosciences, Inc. (NASDAQ: EVFM) (Evofem), a clinical-stage biopharmaceutical company, and PDL BioPharma, Inc. (Nasdaq: PDLI) (PDL) today announced the closing of the second tranche for $50 million of an a… read more...

Evofem Biosciences Closes $80 Million Financing Transaction with PDL BioPharma and Other Long-time Investors

via: PR Newswire at 2019-06-10 12:01:00:000

SAN DIEGO and INCLINE VILLAGE, Nev. , June 10, 2019 /PRNewswire/ --Evofem Biosciences, Inc. (NASDAQ: EVFM) (Evofem), a clinical-stage biopharmaceutical company, and PDL BioPharma, Inc. (Nasdaq: PDLI) (PDL) today announced the closing of the second tranche for $50 million of an a… read more...

Evofem Biosciences Closes $80 Million Financing Transaction with PDL BioPharma and Other Long-time Investors

via: PR Newswire at 2019-06-10 12:01:00:000

SAN DIEGO and INCLINE VILLAGE, Nev. , June 10, 2019 /PRNewswire/ --Evofem Biosciences, Inc. (NASDAQ: EVFM) (Evofem), a clinical-stage biopharmaceutical company, and PDL BioPharma, Inc. (Nasdaq: PDLI) (PDL) today announced the closing of the second tranche for $50 million of an a… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
2016-06-02 2016-06-13 2016-06-06 2016-05-04 0.05 No Change QoQ
2016-03-02 2016-03-11 2016-03-04 2016-02-01 0.05 Decrease
2015-12-02 2015-12-11 2015-12-04 2015-01-29 0.15 No Change QoQ
2015-09-02 2015-09-11 2015-09-04 2015-01-29 0.15 No Change QoQ
2015-06-03 2015-06-12 2015-06-05 2015-01-29 0.15 No Change QoQ
2015-03-03 2015-03-12 2015-03-05 2015-01-29 0.15 No Change QoQ
2014-12-03 2014-12-12 2014-12-05 2014-01-30 0.15 No Change QoQ
2020-09-21 2020-10-01 2020-09-22 2020-09-10 0.075879 Cash
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud